Ancilia Biosciences
PrivateLast Round
Seed
Apr 6, 2026
Total Funding Raised
$7.73M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Ancilia Biosciences is a biotechnology company developing a new class of live biotherapeutics and other microbial products with immunity to key viral pathogens by harnessing the natural power of CRISPR.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ancilia Biosciences Comparables
Compare Ancilia Biosciences with similar companies based on industry and business-model similarity.
Ancilia Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Apr 6, 2026 | ||||
| Grant | Oct 23, 2024 | ||||
| Grant | Oct 23, 2024 | ||||
| Seed | Jul 17, 2024 | ||||
| Grant | Aug 1, 2021 |
Key People
Founding team and executive leadership
Ancilia Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Metaplanet Holdings | Seed |
| NIH RADx | Grant |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Safar Partners | Seed |
| National Institute of Diabetes and Digestive and Kidney Diseases | Grant |
| Spacecadet Ventures | Seed |
| Zubi Capital | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
$10M Seed Round raised.
- Oct 23, 2024
$274K grant received from NIH RADx and NIDDK.
Ancilia Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Ancilia Biosciences's valuation, stock price, and market status.